Prawo i regulacje · 07/01/2020

Solriamfetol Schedules Placement in Schedule IV

The Drug Enforcement Administration has finalized a rule placing solriamfetol, including its salts and isomers, in Schedule IV of the Controlled Substances Act, as previously proposed in 2019.